Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Symtuza TM

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.

Active ingredients: darunavir + cobicistat + emtricitabine + tenofovir alafenamide, darunavir + cobicistat, emtricitabine + tenofovir alafenamide, cobicistat, darunavir, tenofovir alafenamide, emtricitabine

Pack: Symtuza tablet, 30, bottle

Brand name

(ARTG)

: SYMTUZA 800/150/200/10 darunavir/cobicistat/emtricitabine/tenofovir alafenamide 800/150/200/10 mg film-coated tablets

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

What this medicine is used for

(ARTG)

SYMTUZA is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents (aged 12 years and older with body weight at least 40 kg). Genotypic testing should guide the use of SYMTUZA (see section 4.2 Dose and method of administration, section 4.4 Special warnings and precautions for use and section 5.1 Pharmacodynamic properties).

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

  • Tablet, film coated
  • Oral
  • A 2.2 x 1.1 cm, yellow to yellowish brown, capsule-shaped, film-coated tablet, debossed with 8121 on one side and JG on the opposite side.

Storage conditions

(ARTG)

  • Store below 30 degrees Celsius
  • Shelf lifetime is 36 Months.

Do I need a prescription ?

(ARTG)

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient emtricitabine + tenofovir alafenamide

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

For the active ingredient tenofovir alafenamide

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Back to top back to top

Healthdirect 24hr 7 days a week hotline

24 hour health advice you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information and advice

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Queensland Government logo Government of South Australia, health department logo Tasmanian government logo Victorian government logo Government of Western Australia, health department logo

Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and present.